Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene

Hiroko Wakimoto, Colin T. Maguire, Megan C. Sherwood, Marcel M. Vargas, Partha Sarkar, Jennifer Han, Sita Reddy, Charles I. Berul

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Myotonic dystrophy (DM) is an autosomal dominant multisystem disorder, caused by expansion of a CTG trinucleotide repeat in the 3′ untranslated region of the myotonic dystrophy protein kinase gene (DMPK) on chromosome 19q13. Cardiac involvement in DM includes conduction abnormalities and functional deficits. Three hypotheses of molecular mechanisms for DM pathophysiology are; first, partial loss of myotonic dystrophy protein kinase (DMPK); second, decreased transcription of a neighboring homeodomain-encoding gene, Six5 (or DMAHP), and third, transdominant effects of the RNA and regulation of splicing associated with expression of expanded CUG repeats. However, the precise pathogenetic mechanism remains unresolved. We previously reported that dosage of Dm15, the mouse homologue of DMPK, strongly associates with the cardiac conduction abnormalities. For further distinction of the molecular mechanisms underlying the cardiac phenotype of DM, in the present study, we characterized the cardiac conduction findings of mice with targeted disruption of Six5 gene. Six5 heterozygous mice (adult and young) and their age matched wild type littermates were studied using in vivo electrophysiologic techniques, echocardiography, heart rate variability and exercise tolerance testing. No PR prolongation was detected, however, prolonged QRS duration and delayed infraHisian conduction were significant in adult Six5 heterozygous mice. By echocardiography, left ventricular (LV) end-diastolic dimension was enlarged in adult Six5 heterozygous mice, although neither fractioning shortening nor LV wall thickness showed significant differences. Six5 loss may partly contribute to conduction abnormalities in myotonic dystrophy, particularly infraHisian conduction delay, one of the initial phenotypes of adult-onset cardiac conduction abnormalities in DM patients.

Original languageEnglish (US)
Pages (from-to)127-135
Number of pages9
JournalJournal of Interventional Cardiac Electrophysiology
Volume7
Issue number2
DOIs
StatePublished - Oct 2002
Externally publishedYes

Fingerprint

Myotonic Dystrophy
Genes
Echocardiography
RNA Splicing
Phenotype
Trinucleotide Repeats
Exercise Tolerance
3' Untranslated Regions
Young Adult
Chromosomes
Heart Rate
Myotonin-Protein Kinase

Keywords

  • Animal model
  • Atrioventricular conduction
  • Electrophysiology
  • Myotonic dystrophy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene. / Wakimoto, Hiroko; Maguire, Colin T.; Sherwood, Megan C.; Vargas, Marcel M.; Sarkar, Partha; Han, Jennifer; Reddy, Sita; Berul, Charles I.

In: Journal of Interventional Cardiac Electrophysiology, Vol. 7, No. 2, 10.2002, p. 127-135.

Research output: Contribution to journalArticle

Wakimoto, Hiroko ; Maguire, Colin T. ; Sherwood, Megan C. ; Vargas, Marcel M. ; Sarkar, Partha ; Han, Jennifer ; Reddy, Sita ; Berul, Charles I. / Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene. In: Journal of Interventional Cardiac Electrophysiology. 2002 ; Vol. 7, No. 2. pp. 127-135.
@article{cd8e4ac1c5db48ed92167c4e4f97f2aa,
title = "Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene",
abstract = "Myotonic dystrophy (DM) is an autosomal dominant multisystem disorder, caused by expansion of a CTG trinucleotide repeat in the 3′ untranslated region of the myotonic dystrophy protein kinase gene (DMPK) on chromosome 19q13. Cardiac involvement in DM includes conduction abnormalities and functional deficits. Three hypotheses of molecular mechanisms for DM pathophysiology are; first, partial loss of myotonic dystrophy protein kinase (DMPK); second, decreased transcription of a neighboring homeodomain-encoding gene, Six5 (or DMAHP), and third, transdominant effects of the RNA and regulation of splicing associated with expression of expanded CUG repeats. However, the precise pathogenetic mechanism remains unresolved. We previously reported that dosage of Dm15, the mouse homologue of DMPK, strongly associates with the cardiac conduction abnormalities. For further distinction of the molecular mechanisms underlying the cardiac phenotype of DM, in the present study, we characterized the cardiac conduction findings of mice with targeted disruption of Six5 gene. Six5 heterozygous mice (adult and young) and their age matched wild type littermates were studied using in vivo electrophysiologic techniques, echocardiography, heart rate variability and exercise tolerance testing. No PR prolongation was detected, however, prolonged QRS duration and delayed infraHisian conduction were significant in adult Six5 heterozygous mice. By echocardiography, left ventricular (LV) end-diastolic dimension was enlarged in adult Six5 heterozygous mice, although neither fractioning shortening nor LV wall thickness showed significant differences. Six5 loss may partly contribute to conduction abnormalities in myotonic dystrophy, particularly infraHisian conduction delay, one of the initial phenotypes of adult-onset cardiac conduction abnormalities in DM patients.",
keywords = "Animal model, Atrioventricular conduction, Electrophysiology, Myotonic dystrophy",
author = "Hiroko Wakimoto and Maguire, {Colin T.} and Sherwood, {Megan C.} and Vargas, {Marcel M.} and Partha Sarkar and Jennifer Han and Sita Reddy and Berul, {Charles I.}",
year = "2002",
month = "10",
doi = "10.1023/A:1020881520353",
language = "English (US)",
volume = "7",
pages = "127--135",
journal = "Journal of Interventional Cardiac Electrophysiology",
issn = "1383-875X",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene

AU - Wakimoto, Hiroko

AU - Maguire, Colin T.

AU - Sherwood, Megan C.

AU - Vargas, Marcel M.

AU - Sarkar, Partha

AU - Han, Jennifer

AU - Reddy, Sita

AU - Berul, Charles I.

PY - 2002/10

Y1 - 2002/10

N2 - Myotonic dystrophy (DM) is an autosomal dominant multisystem disorder, caused by expansion of a CTG trinucleotide repeat in the 3′ untranslated region of the myotonic dystrophy protein kinase gene (DMPK) on chromosome 19q13. Cardiac involvement in DM includes conduction abnormalities and functional deficits. Three hypotheses of molecular mechanisms for DM pathophysiology are; first, partial loss of myotonic dystrophy protein kinase (DMPK); second, decreased transcription of a neighboring homeodomain-encoding gene, Six5 (or DMAHP), and third, transdominant effects of the RNA and regulation of splicing associated with expression of expanded CUG repeats. However, the precise pathogenetic mechanism remains unresolved. We previously reported that dosage of Dm15, the mouse homologue of DMPK, strongly associates with the cardiac conduction abnormalities. For further distinction of the molecular mechanisms underlying the cardiac phenotype of DM, in the present study, we characterized the cardiac conduction findings of mice with targeted disruption of Six5 gene. Six5 heterozygous mice (adult and young) and their age matched wild type littermates were studied using in vivo electrophysiologic techniques, echocardiography, heart rate variability and exercise tolerance testing. No PR prolongation was detected, however, prolonged QRS duration and delayed infraHisian conduction were significant in adult Six5 heterozygous mice. By echocardiography, left ventricular (LV) end-diastolic dimension was enlarged in adult Six5 heterozygous mice, although neither fractioning shortening nor LV wall thickness showed significant differences. Six5 loss may partly contribute to conduction abnormalities in myotonic dystrophy, particularly infraHisian conduction delay, one of the initial phenotypes of adult-onset cardiac conduction abnormalities in DM patients.

AB - Myotonic dystrophy (DM) is an autosomal dominant multisystem disorder, caused by expansion of a CTG trinucleotide repeat in the 3′ untranslated region of the myotonic dystrophy protein kinase gene (DMPK) on chromosome 19q13. Cardiac involvement in DM includes conduction abnormalities and functional deficits. Three hypotheses of molecular mechanisms for DM pathophysiology are; first, partial loss of myotonic dystrophy protein kinase (DMPK); second, decreased transcription of a neighboring homeodomain-encoding gene, Six5 (or DMAHP), and third, transdominant effects of the RNA and regulation of splicing associated with expression of expanded CUG repeats. However, the precise pathogenetic mechanism remains unresolved. We previously reported that dosage of Dm15, the mouse homologue of DMPK, strongly associates with the cardiac conduction abnormalities. For further distinction of the molecular mechanisms underlying the cardiac phenotype of DM, in the present study, we characterized the cardiac conduction findings of mice with targeted disruption of Six5 gene. Six5 heterozygous mice (adult and young) and their age matched wild type littermates were studied using in vivo electrophysiologic techniques, echocardiography, heart rate variability and exercise tolerance testing. No PR prolongation was detected, however, prolonged QRS duration and delayed infraHisian conduction were significant in adult Six5 heterozygous mice. By echocardiography, left ventricular (LV) end-diastolic dimension was enlarged in adult Six5 heterozygous mice, although neither fractioning shortening nor LV wall thickness showed significant differences. Six5 loss may partly contribute to conduction abnormalities in myotonic dystrophy, particularly infraHisian conduction delay, one of the initial phenotypes of adult-onset cardiac conduction abnormalities in DM patients.

KW - Animal model

KW - Atrioventricular conduction

KW - Electrophysiology

KW - Myotonic dystrophy

UR - http://www.scopus.com/inward/record.url?scp=0036817811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036817811&partnerID=8YFLogxK

U2 - 10.1023/A:1020881520353

DO - 10.1023/A:1020881520353

M3 - Article

VL - 7

SP - 127

EP - 135

JO - Journal of Interventional Cardiac Electrophysiology

JF - Journal of Interventional Cardiac Electrophysiology

SN - 1383-875X

IS - 2

ER -